MentionFox
Home › funding signals › Talos Biotech
Form D · on the record

Talos Biotech — $185K Form D filing, November 2026

Before you sell to, join or invest in Talos Biotech

MentionFox check on Talos Biotech: only 1 source on file so far (checked 20 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/talos-biotech-form-d-000001

Check Talos Biotech before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Talos Biotech?

Talos Biotech filed a Form D with the Securities and Exchange Commission on 2026-11-19.

Talos Biotech filed a Form D notice of an exempt securities offering with the SEC on November 19, 2026. The filing reports $185K sold. Its industry group is Manufacturing. It names William Short (Executive Officer, Director, Promoter), Daniel Finley (Executive Officer) (SEC Form D, November 19, 2026).

Sell to companies like Talos Biotech? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Talos Biotech raised on Nov 19. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

5 more Manufacturing raises within 90 days of this one ↓

Selling to Talos Biotech? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on Talos Biotech →

Talos Biotech

New Form D on file · 2026-11-19 · the record

$185K
raise on the record
D
filing
4
investors in
IDAHO
based
Open the record →

What the record says

FilingForm D
Filed2026-11-19
Industry groupManufacturing
Entity typeCorporation
Incorporated inWYOMING
Year formed2026
BasedPOST FALLS, IDAHO
CIK2156374
Accession0002156374-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Talos Biotech.

Free to see. No signup.

Keep reading

More on the people and the money behind Talos Biotech, from the filings we hold.

More raises like this

Manufacturing raises filed within 90 days of this one, largest first.

What do you want to do with Talos Biotech?

Get the full cited report on Talos Biotech

What the filing shows about Talos Biotech

  • 4 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Talos Biotech: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Talos Biotech up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Talos Biotech's own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Talos Biotech's address as 6224 W Seltice Way, Unit 109, Post Falls, ID 83854.

What the filing says

  • Offered: $300,000. Sold: $185,000. Left to sell: $115,000. (filing)
  • Investors: 4 had already invested. (filing)
  • Date of first sale: September 1, 2026. (filing)
  • Types of securities: Other: Simple Agreement for Future Equity (SAFE). (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Talos Biotech See pricing

Is Talos Biotech a real, registered company?

Talos Biotech is a registered filer with the SEC (CIK 2156374) and has filed since 2026-11-19. 1 filing is on record, the latest on 2026-11-19.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Talos Biotech?

Talos Biotech's Form D of 2026-11-19 names William Short and Daniel Finley as its officers, directors or promoters.

How much has Talos Biotech raised?

Its new offerings report $185K sold across 1 offering, as its own filings state.

Manufacturing · by week
This raise, $185K, filed week of Nov 16

Trailing twelve months. 380 filings in Manufacturing, totalled by week. The dot is this raise, $185K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Talos Biotech?

What the filing shows about Talos Biotech

  • 4 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Talos Biotech: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Talos Biotech covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Talos Biotech. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Talos Biotech: Raised $185K, Form D filed 2026-11-19
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/talos-biotech-form-d-000001
Last updated 2026-11-20
Primary record: SEC filing 1 · SEC filing 2
Talos Biotech raised $185K — SEC Form D filing, November 2026. MentionFox, 2026-11-20. https://mentionfox.com/funding/talos-biotech-form-d-000001